Azilsartan: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | |||
===[[Azilsartan kamedoxomil|Azilsartan Kamedoxomil (Edarbi)]]=== | |||
===[[Azilsartan kamedoxomil and chlorthalidone|Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)]]=== | |||
==Overview== | |||
Azilsartan is a selective AT1 subtype [[angiotensin]] II receptor antagonist used in treatment of [[hypertension]] to lower blood pressure. Common adverse reactions include [[hypotension]]/[[orthostatic hypotension]]. | |||
==Category== | |||
Angiotensin 2 Receptor Blocker | |||
Latest revision as of 05:32, 22 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Azilsartan Kamedoxomil (Edarbi)
Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)
Overview
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of hypertension to lower blood pressure. Common adverse reactions include hypotension/orthostatic hypotension.
Category
Angiotensin 2 Receptor Blocker